Supply of the drug KOVALTRY 2000 IU AIC 044726089 (RECOMBINANT FACTOR VIII COAGULATION ACTIVE INGREDIENT OCTOCOG ALFA)

The Local Health Authority of Biella (Azienda Sanitaria Locale Biella) is seeking the supply of a specific pharmaceutical product: KOVALTRY 2000 IU, with AIC code 044726089. This medication contains recombinant Factor VIII (active ingredient octocog alfa), which is crucial for the treatment of hemophilia A. This tender falls under the category of supplies. The procurement is being conducted through a negotiated procedure without prior publication of a call for tenders (Negoziata senza previa indizione di gara). The estimated value for this supply is EUR 249,600.00. The relevant CPV code is for various medicines. The contract was awarded to BAYER S.p.A. for EUR 174,720.00. This supply is vital for patients with hemophilia A receiving treatment from the ASL Biella, ensuring they have access to necessary life-saving medication. The provision of specialized drugs like KOVALTRY is a critical function of healthcare providers.

This is a supplies contract in the general supplies sector. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 249,600.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.